Invention Grant
- Patent Title: Use of ultrarapid acting insulin
-
Application No.: US15300239Application Date: 2015-03-27
-
Publication No.: US10307464B2Publication Date: 2019-06-04
- Inventor: Anders Hasager Boss , Richard Petrucci
- Applicant: MannKind Corporation
- Applicant Address: US CA Westlake Village
- Assignee: MannKind Corporation
- Current Assignee: MannKind Corporation
- Current Assignee Address: US CA Westlake Village
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Hal Gibson
- International Application: PCT/US2015/022956 WO 20150327
- International Announcement: WO2015/148905 WO 20151001
- Main IPC: A61K38/28
- IPC: A61K38/28 ; A61K31/155 ; A61K9/00
Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Public/Granted literature
- US20170189492A1 Use of Ultrarapid Acting Insulin Public/Granted day:2017-07-06
Information query
IPC分类:
